Follow ZDNET: Add us as a preferred source on Google. Web browsers are among the most essential pieces of software we use daily, yet we often take them for granted. Most users settle for whatever ...

Most adults know the drill before an annual physical: routine blood work, a few numbers to scan, and hope nothing jumps out. These tests are meant to catch serious illness early. But when it comes to ...

More than a year after the first prototype surfaced on the PGA Tour, Cobra has finally joined the mini driver fray at retail. Cobra is releasing the King Tec Mini Driver, becoming the latest OEM to ...

A new University of Washington study links license plate lookups through a Washington State Patrol “switchboard” to immigration arrests. 5 takeaways from new polls of the Minneapolis ICE shooting She ...

Chethan is a reporter at Android Police, focusing on the weekend news coverage for the site. He has covered tech for over a decade with multiple publications, including the likes of Times Internet, ...

In a new experiment, Meta is limiting the number of links users can post on Facebook, unless they have a paid Meta Verified subscription. According to the screenshot posted by Navarra, users can still ...

In this talk, Jaswanth Manigundan shares a practical view of how AI and the Playwright MCP server can support day to day web testing. He draws on his experience as a tester, automation engineer, and ...

In a move that could redefine the web, Google is testing AI-powered, UI-based answers for its AI mode. Up until now, Google AI mode, which is an optional feature, has allowed you to interact with a ...

What if you could eliminate one of the most frustrating bottlenecks in web development with a single tool? For years, developers have wrestled with the inefficiency of manually transferring CSS tweaks ...

The new Gemini 2.5 Computer Use model can click, scroll, and type in a browser window to access data that’s not available via an API. The new Gemini 2.5 Computer Use model can click, scroll, and type ...

Immune cells can target cancer in the clinic. The ability to test a gene-editing technology in mice on a large scale should improve such immunotherapies. Michael Hudecek is in the Department of ...